Colgate-Palmolive (India) Ltd (COLPAL) — shareholding pattern, promoter holding, financials and share price
About Colgate-Palmolive (India) Ltd (COLPAL)
Colgate-Palmolive (India) Ltd operates in the Personal Care industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as COLPAL and on the BSE under scrip code 500830. Its ISIN is INE259A01022.
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products. [1]
Colgate-Palmolive (India) Limited is a leading provider of oral care products, offering toothpastes, toothpowder, toothbrushes, and mouthwashes under the 'Colgate' brand, alongside personal care products under 'Palmolive'.
The company ended FY 2024-25 with a revenue of Rs. 5,999 crores, marking a 6.3% growth driven by strong performances in toothpaste and toothbrush categories. EBITDA margins stood at 32.6%.
Listed peers in Personal Care: Dabur India Ltd, Procter & Gamble Hygiene and Health Care Ltd, Cupid Ltd, Gillette India Ltd, Emami Ltd, Honasa Consumer Ltd.
Valuation & Returns
10 Jul 2026At ₹2,052 a share on 10 Jul 2026, Colgate-Palmolive (India) Ltd (COLPAL) was valued at a price-to-earnings ratio of 42.11x against an industry P/E of 46.1x and a price-to-book of 35.23x on a book value of ₹58.24 per share as of Mar 2026. Solomo computes return on equity of 83.66% and return on capital employed of 109.58% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 42.11x
- Industry P/E
- 46.1x
- P/B
- 35.23x
- EPS (TTM)
- ₹48.73
- Book value / share
- ₹58.24
- ROE
- 83.66%
- ROCE
- 109.58%
- ROA
- 38.89%
- Debt / equity
- 0.03x
- Dividend yield
- 2.34%
- EBITDA margin
- 32.32%
- 52-week range
- ₹1,781.6 – ₹2,505
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2010In the year ended Mar 2010, Colgate-Palmolive (India) Ltd (COLPAL) reported revenue of ₹1,960 crore, net profit of ₹436 crore and earnings per share of ₹15.96. That compares with revenue of ₹1,698 crore and net profit of ₹288 crore in Mar 2009. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹1,595 crore and net profit ₹353 crore (standalone).
| Metric | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,129 | 1,291 | 1,470 | 1,698 | 1,960 |
| Net profit (₹ cr) | 140 | 148 | 237 | 288 | 436 |
| EPS (₹) | 5.15 | 5.46 | 8.67 | 10.51 | 15.96 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 3.26% | 4.51% | 4.91% | 15.38% |
| Profit growth | 9.67% | 5.06% | 8.17% | 51.13% |
| Stock price CAGR | 8% | 3% | 3% | -16% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 51% of Colgate-Palmolive (India) Ltd (COLPAL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 13.59% and domestic institutional investors (DII) hold 15.82%. Market capitalisation was ₹55,811 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Life Insurance Corporation Of India 5.39%, Sbi Large & Midcap Fund 3.15%, Nippon Life India Trustee Ltd-A/C Nippon India Multi Cap Fund 1.67%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 51% | - | 13.59% | 15.82% | 49% |
| Mar 2026 | 51% | - | 13.6% | 15.53% | 49% |
| Dec 2025 | 51% | - | 15.18% | 13.79% | 49% |
| Sep 2025 | 51% | - | 17.16% | 12.23% | 49% |
| Jun 2025 | 51% | - | 20.39% | 9.62% | 49% |
| Mar 2025 | 51% | - | 22.22% | 8.12% | 49% |
| Dec 2024 | 51% | - | 23.72% | 6.83% | 49% |
| Sep 2024 | 51% | - | 24.94% | 5.83% | 49% |